Viral Vector Purification Market Report 2026

Viral Vector Purification Market Overview

• Viral Vector Purification market size has reached to $1.75 billion in 2025 • Expected to grow to $3.98 billion in 2030 at a compound annual growth rate (CAGR) of 17.8% • Growth Driver: Rising Demand For Gene Therapies Fueling The Growth Of The Market Due To Increasing Need For Safe And High-Quality Viral Vectors • Market Trend: Rapid High-Throughput Analytical Solutions Improve Efficiency And Purity • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Viral Vector Purification Market?

Viral vector purification is the process of isolating viral vectors from production impurities, such as host cell proteins, DNA, and other contaminants, to obtain a highly pure and safe product. Its primary purpose is to ensure the viral vectors are suitable for therapeutic use, maintaining efficacy and safety in gene therapy applications. The main vector types of viral vector purification are adenoviral vectors, lentiviral vectors, adeno-associated viral vectors, retroviral vectors, and others. Adenoviral vectors refer to viruses engineered for delivering genetic material into cells, commonly used in gene therapy and vaccine development. It includes product types such as kits, reagents, instruments, and services utilizing different purification techniques such as chromatography, ultrafiltration, precipitation, and others. The various applications involve gene therapy, vaccinology, research, and others, serving end users such as pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and others.

What Is The Viral Vector Purification Market Growth Forecast?

The viral vector purification market size is expected to see rapid growth in the next few years. It will grow to $3.98 billion in 2030 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to increasing demand for clinical-grade viral vectors, rising investments in downstream bioprocessing technologies, expansion of gene therapy pipelines, growing adoption of automated purification platforms, increasing regulatory scrutiny on product purity. Major trends in the forecast period include increasing adoption of high-resolution chromatography techniques, rising demand for scalable purification solutions, growing use of single-use purification systems, expansion of high-purity vector isolation processes, enhanced focus on process yield optimization.

Global Viral Vector Purification Market Segmentation

1) By Vector Type: Adenoviral Vectors, Lentiviral Vectors, Adeno-Associated Viral Vectors, Retroviral Vectors, Other Vector Types 2) By Product Type: Kits, Reagents, Instruments, Services 3) By Purification Technique: Chromatography, Ultrafiltration, Precipitation, Other Purification Techniques 4) By Application: Gene Therapy, Vaccinology, Research, Other Applications 5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users Subsegments: 1) By Adenoviral Vectors: First Generation, Second Generation, Third Generation 2) By Lentiviral Vectors: Integrating Lentiviral Vectors, Non Integrating Lentiviral Vectors 3) By Adeno Associated Viral Vectors: Recombinant Adeno Associated Viral Vectors, Self Complementary Adeno Associated Viral Vectors 4) By Retroviral Vectors: Gamma Retroviral Vectors, Alpha Retroviral Vectors, Beta Retroviral Vectors

What Is The Driver Of The Viral Vector Purification Market?

The rising demand for gene therapies is expected to propel the growth of the viral vector purification market going forward. Gene therapies are medical treatments that involve introducing, removing, or altering genetic material within a patient’s cells to treat or prevent diseases. The demand for gene therapies is increasing due to advancements in delivery systems, as they enable safe, efficient, and targeted transport of genetic material into cells. Viral vector purification enhances gene therapies by ensuring high-quality, safe, and biologically active viral vectors. It improves therapy effectiveness by removing impurities and optimizing vector performance, supporting reliable and efficient treatment outcomes. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the rising demand for gene therapies is driving the growth of the viral vector purification industry.

Key Players In The Global Viral Vector Purification Market

Major companies operating in the viral vector purification market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, FUJIFILM Diosynth Biotechnologies, Danaher Corporation, Sartorius AG, Agilent Technologies Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Bio‑Rad Laboratories Inc., AGC Biologics A/S, Takara Bio Inc., Miltenyi Biotec B.V. & Co. KG, Oxford Biomedica PLC, Revvity Inc., Applied Biological Materials Inc. (ABM), Creative Biolabs Inc., Repligen Corporation, Asahi Kasei Corporation, Promega Corporation, 3M Company

Global Viral Vector Purification Market Trends and Insights

Major companies operating in the viral vector purification market are focusing on rapid, high-throughput analytical solutions, such as macro mass photometry platforms, to enhance process efficiency, ensure vector purity, and reduce development timelines. Macro mass photometry platforms refer to instruments that use light scattering to measure both the size and mass of viral particles, enabling precise assessment of empty versus full capsids and detection of degraded particles in minutes. For instance, in November 2023, Refeyn Ltd., a UK-based biotechnology company, launched KaritroMP, a macro mass photometry platform, which analyzes adenovirus and lentivirus vectors within six minutes. The platform offers semi-automated sample processing for up to 13 samples, delivers high reproducibility for quality control, and allows detection of subtle differences in particle mass to support purification optimization. This launch strengthens the capabilities of viral vector manufacturers by providing faster and more precise assessment of vector quality. It also helps streamline workflow efficiency, reducing time and resources required for vector characterization and purification.

What Are Latest Mergers And Acquisitions In The Viral Vector Purification Market?

In September 2025, Thermo Fisher Scientific Inc., a US-based scientific instruments and life sciences company, acquired Solventum’s purification and filtration business for approximately $4.0 billion. Through this acquisition, Thermo Fisher strengthens its bioprocessing portfolio by integrating Solventum’s advanced purification and filtration technologies to enhance quality, efficiency, and end-to-end capabilities across upstream and downstream viral vector manufacturing workflows. Solventum Corporation is a US-based healthcare company that provides bioprocessing filtration and purification solutions, including products applicable to viral vector purification.

Regional Outlook

North America was the largest region in the viral vector purification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viral Vector Purification Market?

The viral vector purification market includes revenues earned by entities through process development, analytical testing, formulation development, chromatography, ultrafiltration, precipitation, quality control, viral clearance validation, scale-up optimization, and stability testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Viral Vector Purification Market Report 2026?

The viral vector purification market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector purification industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.